NCT05533892 2023-12-19
CCGLC-007
Tongji Hospital
Phase 1 Unknown
Clinical Trials
5 trialsNCT05798533 2023-07-10
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
BGI, China
Phase 1 Unknown
NCT05675462 2023-03-06
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Fudan University
Phase 1 Unknown
NCT05441046 2022-07-06
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT05008861 2021-08-17
Gut Microbiota Reconstruction for NSCLC Immunotherapy
Shanghai Zhongshan Hospital
Phase 1 Unknown